CoChat

Semaglutide ameliorates pressure overload-induced cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome

Open access
He, Wenxiu, Wei, Jiahe, Liu, Xing, Zhang, Zhongyin, Huang, Rongjie, Jiang, Zhiyuan · 2024 · Scientific Reports

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Abstract

Pathological cardiac hypertrophy is an important cause of heart failure(HF). Recent studies reveal that glucagon-like peptide-1 receptor (GLP1R) agonists can improve mortality and left ventricular ejection fraction in the patients with type 2 diabetes and HF. The present study aims to investigate whether semaglutide, a long-acting GLP1R agonist, can ameliorate cardiac hypertrophy induced by pressure overload, and explore the potential mechanism. The rats were performed transverse aortic constriction (TAC) to mimic pressure overload model. The rats were divided into four groups including Sham, TAC, TAC + semaglutide, and TAC + semaglutide + HCQ (hydroxychloroquine, an inhibitor of mitophagy). The rats in each experimental group received their respective interventions for 4 weeks. The parameters of left ventricular hypertrophy(LVH) were measured by echocardiography, Hematoxylin–eosin (HE) staining, western-blot and immunohistochemistry (IHC), respectively. The changes of mitophagy were reflected by detecting cytochrome c oxidase subunit II (COXII), LC3II/LC3I, mitochondria, and autophagosomes. Meanwhile, NLRP3, Caspase-1, and interleukin-18 were detected to evaluate the activation of NLRP3 inflammasome in each group. The results suggest that LVH, impaired mitophagy, and activation of NLRP3 inflammasome were present in TAC rats. Semaglutide significantly reduced LVH, improve mitophagy, and down-regulated NLRP3 inflammatory signal pathway in TAC rats. However, the reversed effect of semaglutide on cardiac hypertrophy was abolished by HCQ, which restored the activation of NLRP3 inflammasome suppressed by improved mitophagy. In conclusion, semaglutide ameliorates the cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome. Semaglutide may be a novel potential option for intervention of cardiac hypertrophy induced by pressure overload.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-024-62465-6

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Semaglutide mitigated pressure overload-induced left ventricular hypertrophy. (A) Representative images of LVPWT and IVST measured by M-mode doppler echocardiography, and LVPWT, IVST and LVMI of rats in each group(n = 6 in each group) (B) Representative longitudinal sections of the whole hearts by HE staining, and LVWT of rats in each group(n = 3 in each group). LVPWT left ventricular posterior wall thickness, IVST inter-ventricular septum thickness, LVMI left ventricular mass index, LVWT left ventricular wall thickness, TAC transverse aortic constriction. **P < 0.01, ***P < 0.001, and ****P < 0.0001.
Figure 1 Semaglutide mitigated pressure overload-induced left ventricular hypertrophy. (A) Representative images of LVPWT and IVST measured by M-mode doppler echocardiography, and LVPWT, IVST and LVMI of rats in each group(n = 6 in each group) (B) Representative longitudinal sections of the whole hearts by HE staining, and LVWT of rats in each group(n = 3 in each group). LVPWT left ventricular posterior wall thickness, IVST inter-ventricular septum thickness, LVMI left ventricular mass index, LVWT left ventricular wall thickness, TAC transverse aortic constriction. **P < 0.01, ***P < 0.001, and ****P < 0.0001.CC BY · PubMed Central
Figure 2 Semaglutide mitigated pressure overload-induced left ventricular hypertrophy by improving mitophagy dysfunction. (A) Representative images COX II, LC3I, and LC3II measured by Western-blot, and relative expression of COX II and LC3II/LC3I ratio of rat’s heart in each group (n = 6 in each group). (B) Representative immunohistochemical images of COX II (500 ×), and the expression of COX II of rat’s heart in each group (n = 6 in each group). (C) Representative images of TEM showing the quantity of mitochondria, and the relative quantity of mitochondria of rat’s heart in each group (7000 ×) (n = 6 in each group). (D) Representative images of TEM showing the quantity of autophagosome, and the relative quantity of autophagosome of rat’s heart in each group (7000 ×) (n = 6 in each group). The red arrows indicate typical mitochondria, the autophagosomes were included in a red box, which is amplified in the right pictures. (E) Representative images of LVPWT and IVST measured by M-mode doppler echocardiography, and LVPWT, IVST and LVMI of rats in each group(n = 6 in each group). (F) Representative longitudinal sections of the whole hearts by HE staining, and LVWT of rats in each group (500 ×) (n = 3 in each group). LVPWT left ventricular posterior wall thickness, IVST inter-ventricular septum thickness, LVMI left ventricular mass index, LVWT left ventricular wall thickness, TAC transverse aortic constriction, HCQ hydroxychloroquine, an inhibitor of mitophagy. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
Figure 2 Semaglutide mitigated pressure overload-induced left ventricular hypertrophy by improving mitophagy dysfunction. (A) Representative images COX II, LC3I, and LC3II measured by Western-blot, and relative expression of COX II and LC3II/LC3I ratio of rat’s heart in each group (n = 6 in each group). (B) Representative immunohistochemical images of COX II (500 ×), and the expression of COX II of rat’s heart in each group (n = 6 in each group). (C) Representative images of TEM showing the quantity of mitochondria, and the relative quantity of mitochondria of rat’s heart in each group (7000 ×) (n = 6 in each group). (D) Representative images of TEM showing the quantity of autophagosome, and the relative quantity of autophagosome of rat’s heart in each group (7000 ×) (n = 6 in each group). The red arrows indicate typical mitochondria, the autophagosomes were included in a red box, which is amplified in the right pictures. (E) Representative images of LVPWT and IVST measured by M-mode doppler echocardiography, and LVPWT, IVST and LVMI of rats in each group(n = 6 in each group). (F) Representative longitudinal sections of the whole hearts by HE staining, and LVWT of rats in each group (500 ×) (n = 3 in each group). LVPWT left ventricular posterior wall thickness, IVST inter-ventricular septum thickness, LVMI left ventricular mass index, LVWT left ventricular wall thickness, TAC transverse aortic constriction, HCQ hydroxychloroquine, an inhibitor of mitophagy. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.CC BY · PubMed Central
Figure 3 Semaglutide ameliorated pressure overload-induced cardiac hypertrophy by improving mitophagy to suppress the activation of NLRP3 inflammasome. (A) Representative images MYH7 and ANP measured by Western-blot, and relative expression of MYH7 and ANP of rat’s heart in each group(n = 6 in each group). (B) Representative immunohistochemical images of MYH7 (500 ×), and the expression of MYH7 of rat’s heart in each group(n = 6 in each group). (C) Representative immunohistochemical images of ANP (500 ×), and the expression of ANP of rat’s heart in each group(n = 6 in each group). (D) Representative images NLRP3, Caspase-1, and IL-18 measured by Western-blot, and relative expression of NLRP3, Caspase-1, and IL-18 of rat’s heart in each group(n = 6 in each group). (E) Representative immunohistochemical images of NLRP3 (500 ×), and the expression of NLRP3 of rat’s heart in each group(n = 6 in each group). (F) Representative immunohistochemical images of IL-18 (500 ×), and the expression of IL-18 of rat’s heart in each group(n = 6 in each group). (g) Representative sections of HE staining to observe inflammatory cell infiltration (500 ×)(n = 6 in each group). TAC transverse aortic constriction, HCQ hydroxychloroquine, an inhibitor of mitophagy. **P < 0.01, ***P < 0.001, and ****P < 0.0001.
Figure 3 Semaglutide ameliorated pressure overload-induced cardiac hypertrophy by improving mitophagy to suppress the activation of NLRP3 inflammasome. (A) Representative images MYH7 and ANP measured by Western-blot, and relative expression of MYH7 and ANP of rat’s heart in each group(n = 6 in each group). (B) Representative immunohistochemical images of MYH7 (500 ×), and the expression of MYH7 of rat’s heart in each group(n = 6 in each group). (C) Representative immunohistochemical images of ANP (500 ×), and the expression of ANP of rat’s heart in each group(n = 6 in each group). (D) Representative images NLRP3, Caspase-1, and IL-18 measured by Western-blot, and relative expression of NLRP3, Caspase-1, and IL-18 of rat’s heart in each group(n = 6 in each group). (E) Representative immunohistochemical images of NLRP3 (500 ×), and the expression of NLRP3 of rat’s heart in each group(n = 6 in each group). (F) Representative immunohistochemical images of IL-18 (500 ×), and the expression of IL-18 of rat’s heart in each group(n = 6 in each group). (g) Representative sections of HE staining to observe inflammatory cell infiltration (500 ×)(n = 6 in each group). TAC transverse aortic constriction, HCQ hydroxychloroquine, an inhibitor of mitophagy. **P < 0.01, ***P < 0.001, and ****P < 0.0001.CC BY · PubMed Central
Figure 4 The potential mechanism of semaglutide improving cardiac hypertrophy induced by pressure overload.
Figure 4 The potential mechanism of semaglutide improving cardiac hypertrophy induced by pressure overload.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 30

Metadata

Authors
He, W., Wei, J., Liu, X., Zhang, Z., Huang, R., & Jiang, Z.
Affiliations
Guangxi Medical University (CN)
Corresponding author
  • Huang, Rongjie
  • Jiang, Zhiyuan
Venue
Scientific Reports
Published
2024-05-23
Volume
14
Issue
1
Pages
11824-11824
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4398251241
Cited by
30
References
42
Citations by year
2026: 13 · 2025: 14 · 2024: 3
FWCI
9.03
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (NO. 82160066)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
semaglutide, cardiac hypertrophy, pressure overload, mitophagy, NLRP3 inflammasome, GLP-1 receptor agonists, transverse aortic constriction, hydroxychloroquine, left ventricular hypertrophy, heart failure, autophagy, caspase-1, IL-18
MeSH terms
Glucagon-Like Peptide-1 Receptor, NLR Family, Pyrin Domain-Containing 3 Protein, Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Animals, Disease Models, Animal, Glucagon-Like Peptides, Cardiomegaly, Male, Rats, Sprague-Dawley, Hypertrophy, Left Ventricular, Rats, Inflammasomes, Mitophagy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Semaglutide ameliorates pressure overload-induced cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome. https://app.cochat.ai/papers/10.1038/s41598-024-62465-6
The paper
He, W., Wei, J., Liu, X., Zhang, Z., Huang, R., & Jiang, Z. (2024). Semaglutide ameliorates pressure overload-induced cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome. Scientific Reports. https://doi.org/10.1038/s41598-024-62465-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.